ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 48300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 48300; 2) Community: the network communities that were significantly associated with the response to NSC 48300; 3) Molecule: the relationships between components within communities and NSC 48300; 4) MDR: the compounds that were significantly associated with the NSC 48300.

NSC Compound Enrichment Correlation
NSC 674268 Null 0.0403978426119741 0.081017692
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0403978426119741 0.53379009
NSC 681633 Camptothecin Derivative 0.0403978426119741 0.36868985
NSC 683694 Null 0.0403978426119741 0.37889635
NSC 683766 Benzoic acid, 4-[[(2-bromi-3,6-dioxo-1,4-cyclohexadienyl)methyl]-amino]-, 1-adamantyl ester 0.0403978426119741 0.30350526
NSC 685828 7H-Purine, 6-chloro-7-[2-deoxy-3-O-(4-methylphenyl)- 4-(4-methylphenoxy)-.beta.-D-erythrofuranosyl]- 0.0403978426119741 0.20423002
NSC 691085 Null 0.0403978426119741 0.18342241
NSC 692574 Null 0.0403978426119741 0.55404347
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0403978426119741 0.5223424
NSC 700363 Liposomal Annamycin 0.0403978426119741 0.26242286
Total:122  Current:111    [First] [Prev] [Next] [Last]